Locust Walk appointed Strategic and Business Development Advisor for the licensing process of ILB™
Viken – 9th March 2019 – TIKOMED, a Swedish privately held biopharmaceutical company today announced the appointment of Locust Walk (LW) as strategic advisor and business development representative for the licensing process of ILB™. “We are very pleased to secure this new collaboration as we have already worked closely with Locust Walk over the past twelve months, assessing our ILB™ portfolio and exploring our commercialization opportunities within different neurodegenerative disease areas such as ALS. With their proven track record and in-depth market insights in the field of